Antidepressant-induced mania and cycle acceleration: A controversy revisited

American Journal of Psychiatry

Volumn 152, Issue 8, 1995, Pages 1130-1138

  Altshuler, Lori L ^b   Post, Robert M ^a   Leverich, Gabriele S ^b   Mikalauskas, Kirstin ^b   Rosoff, Ann ^b   Ackerman, Laura ^b  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CARBAMAZEPINE; CHLORPROMAZINE; DESIPRAMINE; LITHIUM; MONOAMINE OXIDASE INHIBITOR; NEUROLEPTIC AGENT; NORTRIPTYLINE; TRAZODONE;

ADULT; ARTICLE; DISCRIMINANT ANALYSIS; DRUG INDUCED DISEASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MANIA; MANIC DEPRESSIVE PSYCHOSIS; PRIORITY JOURNAL;

EID: 0029145299     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.152.8.1130     Document Type: Article

References (90)

1. Seager CP, Bird RL: Imipramine with ECT in depression: a controlled trial. J Ment Sci 1962; 108:704-707
2. Kay DW, Fahy T, Garside RF: A seven-month double-blind trial of amitriptyline and diazepam in ECT-treated depressed patients. Br J Psychiatry 1970; 117:667-671
3. Mindham RHS, Howland DC, Shepherd M: Continuation therapy with tricyclic antidepressants in depressive illness. Lancet 1972; 2:854-855
4. Prien RF, Klett CJ, Caffey EM Jr: Lithium carbonate and imipramine in prevention of affective episodes: a comparison in recurrent affective illness. Arch Gen Psychiatry 1973; 29:420-425
5. Prien RF, Kupfer DJ, Mansky PA, Small JG, Tuason VB, Voss CB, Johnson WE: Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders. Arch Gen Psychiatry 1984; 41:1096-1104
6. Klerman GL, DiMascio A, Weissman MM, Prusoff B, Paykel ES: Treatment of depression by drugs and psychotherapy. Am J Psychiatry 1974; 131:186-191
7. Coppen A, Ghose K, Montgomery S, Rama-Rao VA, Bailey J, Jorgensen A: Continuation therapy with amitriptyline in depression. Br J Psychiatry 1978; 133:28-33
8. van Praag H, de Hann S: Depression vulnerability and 5-hydroxytryptophan prophylaxis. Psychiatry Res 1980; 3:75-83
9. Stein MK, Rickeis K, Weise CC: Maintenance therapy with amitriptyline: a controlled trial. Am J Psychiatry 1980; 137:370-371
10. Rouillon F, Phillips R, Serrurier D, Amsart E, Gerard MJ: Rechutes des dépressions unipolaires et efficacité de la maprotiline. L'Encéphale 1989; 15:527-534
11. Kane JM, Quitkin PM, Rifkin A, Ramos-Lorenz JR, Noyak HA: Lithium carbonate and imipramine in the prophylaxis of unipolar and bipolar II illness. Arch Gen Psychiatry 1982; 39:1065-1069
12. Bialos D, Giller E, Jatlow P, Docherty J, Harkness L: Recurrence of depression after discontinuation of long-term amitriptyline treatment. Am J Psychiatry 1982; 139:325-329
13. Glen AIM, Johnson Al, Shepherd M: Continuation therapy with lithium and amitriptyline in unipolar depressive illness: a randomized double-blind controlled trial. Psychol Med 1984; 14:37-50
14. Montgomery SA, Dufour M, Brion S, Gailledreau J, Laqueille X, Ferrey G, Moron P, Parant-Lucena N, Singer L, Danion JN, Beuzen JN, Pierredon MA: The prophylactic efficacy of fluoxetine in unipolar depression. Br J Psychiatry 1988; 193(Sept suppl):69-76
15. Lendresse P, Cren MC, Lemarie JC: Traitement prolongé par nomifensine 75 mg dans les états dépressifs névrotiques et réactionnels. Psychiatrie Française 1984; 16(suppl):156-158
16. Frank E, Kupfer DJ, Perel JM, Cornes C, Jarrett DB, Mallinger AG, Thase ME, McEachran AB, Grochocinski VJ: Three-year outcomes for maintenance therapies in recurrent depression. Arch Gen Psychiatry 1990; 47:1093-1099
17. Kupfer DJ, Frank E, Perel JM, Cornes C, Jarrett DB, Mallinger AG, Thase ME, McEachran AB, Grochocinski VJ: Five-year outcome for maintenance therapies in recurrent depression. Arch Gen Psychiatry 1992; 49:769-773
18. Henry EW, Chandler LP, Rasmussen JGC: Assessment of manic reactions during treatment with the SSRI sertraline. Clin Neuropharmacol 1992; 15(suppl 1):317
19. Angst J, Dittrich A, Grof P: Course of endogenous affective psychoses and its modification by prophylactic administration of imipramine and lithium. Int Pharmacopsychiatry 1969; 2:1-11
20. Crane GE: The psychiatric side-effects of iproniazid. Am J Psychiatry 1956; 112:494-501
21. Siegel D: Bulimia, tricyclic antidepressants, and mania. Clinical Pediatr (Phila) 1989; 28:123-126
22. Kukopulos A, Reginaldi D, Laddomada P, Floris G, Serra G, Tondo L: Course of the manic-depressive cycle and changes caused by treatment. Pharmakopsychiatrie Neuro-Psychopharmakologie 1980; 13:156-167
23. Ball JR, Kiloh LG: A controlled trial of imipramine in treatment of depressive states. Br Med J 1959; 2:1052-1055
24. Leyberg JT, Denmark JC: The treatment of depressive states with imipramine hydrochloride (Tofranil). J Ment Sci 1959; 105: 1123-1126
25. Kiloh LG, Child JP, Latner G: Controlled trial of iproniazid in the treatment of endogenous depression. J Ment Sci 1960; 106: 1139-1144
26. Klein DF: Chlorpromazine-procyclidine combination, imipramine and placebo in depressive disorders. Can Psychiatr Assoc J 1966; 11(Suppl):146-149
27. Bartholomew AA: Evaluation of tranylcypromine ("Parnate") in the treatment of depression. Med J Aust 1962; 49:655-662
28. Rees L, Davies B: A controlled trial of phenelzine ("Nardil") in the treatment of severe depressive illness. J Ment Sci 1961; 107:560-566
29. Hohn R, Gross GM, Gross M, Lasagna L: A double-blind comparison of placebo and imipramine in the treatment of depressed patients in a state hospital. J Psychiatr Res 1961; 1:76-91
30. Miller A, Baker EFW, Lewis D, Jones A: Imipramine: a clinical evaluation in a variety of settings. Can Psychiatr Assoc J 1960; 5:150-160
31. Freyhan FA: Zur modernen psychiatrischen Behandlung der Depressionen. Nervenarzt 1960; 31:112-118
32. Browne MW, Kreeger LC, Kazamias NG: A clinical trial of amitriptyline in depressive patients. Br J Psychiatry 1963; 109:692-694
33. Gottfries CG: Clinical trial with the monoamine oxidase inhibitor tranylcypromine on a psychiatric clientele. Acta Psychiatr Scand 1963; 39:463-472
34. Skarbek A: Trial of amitriptyline in chronic depression. Dis Nerv Syst 1963; 24:115-119
35. Vahia NS, Bagadia VCN, Doongaji DR: Value of some antidepressants. Hospital Reports by the Medical and Professorial Staff of the Jamsetji Jijibhai Hospital and Grant Medical College 1964; 9:199-203
36. Arnold OH, Kryspin-Exner K: Zur Frage der Beeinflussung des Verlaufes des manisch-depressiven Krankheitgeschehens durch Antidepressive (On the question of the influence of antidepressants on the course of manic-depressive illness). Wien Med Wochenschr 1965; 45/46:929-934
37. Till E, Vukovic S: Uber den Einfluss der thymoleptischen Behandlung auf den Verlauf endogener Depressionen (On the influences of thymoleptic treatment on the course of endogenous depression). Int Pharmacopsychiatry 1970; 4:210-219
38. Murphy DL: The behavioral toxicity of monoamine oxidase-inhibiting antidepressants. Adv Pharmacol Chemother 1977; 14:71-105
39. Murphy DL, Brand E, Baker M, van Kammen D, Gordon E: Phenelzine effects in hospitalized unipolar and bipolar depressed patients: behavioral and biochemical relationships, in Neuropsychopharmacology: Proceedings of the IX Congress of the CINP, 7-12 July, 1974. Edited by Bossier JR, Hippius H, Pichot P. New York, American Elsevier, 1975
40. Bunney WE Jr: Psychopharmacology of the switch process in affective illness, in Psychopharmacology: A Generation of Progress. Edited by Lipton MA, DiMascio A, Killiam KF. New York, Raven Press, 1978
41. Van Schenyen JC, van Kammen DP: Clomipramine-induced mania in unipolar depression. Arch Gen Psychiatry 1979; 36:560-565
42. Akiskal HS: External validating criteria for psychiatric diagnosis: their application in affective disorders. J Clin Psychiatry 1980; 41:6-15
43. Wehr TA, Goodwin FK: Do antidepressants cause mania? Psychopharmacol Bull 1987; 23:61-65
44. Quitkin FM, Kane J, Rifkin A, Lorenzi-Ramos JR, Nayak DV: Prophylactic lithium carbonate with and without imipramine for bipolar I patients. Arch Gen Psychiatry 1981; 38:902-907
45. Wehr TA, Goodwin FK: Can antidepressants cause mania and worsen the course of affective illness? Am J Psychiatry 1987; 144:1403-1411
46. Zis AP, Cowdry RW, Wehr TA, Muscetolla G, Goodwin FK: Tricyclic-induced mania and MHPG excretion. Psychiatry Res 1979; 1:93-99
47. Geller B, Fox L, Fletcher M: Effect of tricyclic antidepressants on switching to mania and on the onset of bipolarity in depressed 6-12 year olds. J Am Acad Child Adolesc Psychiatry 1993; 32:43-50
48. Wehr TA, Goodwin FK: Tricyclics modulate frequency of mood cycles. Chronobiologia 1979; 6:377-385
49. Wehr TA, Goodwin FK: Rapid cycling in manic-depressives induced by tricyclic antidepressants. Arch Gen Psychiatry 1979; 36:555-559
50. Wehr TA, Goodwin FK: Rapid cycling between mania and depression caused by maintenance tricyclics. Psychopharmacol Bull 1979; 15:17-21
51. Ghadirian AM, Kusalic M: Rapid cycling following antidepressant in an adolescent. Biol Psychiatry 1990; 27:1183-1184
52. Extein I, Pottash ALC, Gold MS: Does subclinical hypothyroidism predispose to tricyclic-induced rapid mood cycles? J Clin Psychiatry 1982; 43:290-293
53. Oppenheim G: Drug-induced rapid cycling: possible outcomes and management. Am J Psychiatry 1982; 139:939-941
54. Siris SG, Chertoff HR, Perel JM: Rapid-cycling affective disorder during imipramine treatment: a case report. Am J Psychiatry 1979; 136:341-342
55. Lerer B, Birmacher B, Ebstein RP, Belmaker RH: 48-hour depressive cycling induced by antidepressant. Br J Psychiatry 1980; 137:183-185
56. Kukopulos A, Caliari B, Tundo A, Minnai G, Floris G, Reginaldi D, Tondo L: Rapid cyclers, temperament, and antidepressants. Compr Psychiatry 1983; 24:249-258
57. Ko GN, Leckman JF, Heninger GR: Induction of rapid mood cycling during L-dopa treatment in a bipolar patient. Am J Psychiatry 1981; 138:1624-1625
58. Mattsson A, Seltzer RL: MAOI-induced rapid cycling bipolar affective disorder in an adolescent. Am J Psychiatry 1981; 138:677-679
59. Wehr TA, Sack DA, Rosenthal NE, Cowdry RW: Rapid cycling affective disorder: contributing factors and treatment responses in 51 patients. Am J Psychiatry 1988; 145:179-184
60. Tondo L, Laddomada P, Serra G, Minnai G, Kukopulos A: Rapid cyclers and antidepressants. Int Pharmacopsychiatry 1981; 16:119-123
61. Tondo L, Burrai C, Scamonatti L, Rudas N: Effect of lithium discontinuation on rapid cycling course. Lithium 1990; 1:221-226
62. Solomon RL, Rich CL, Darko DF: Antidepressant treatment and the occurrence of mania in bipolar patients admitted for depression. J Affect Disord 1990; 18:253-257
63. Angst J: Switch from depression to mania, or from mania to depression: role of psychotropic drugs. Psychopharmacol Bull 1987; 23:66-67
64. Angst J: Switch from depression to mania - a record study over decades between 1920 and 1982. Psychopathology 1985; 18:140-154
65. Kupfer DJ, Carpenter LL, Frank E: Possible role of antidepressants in precipitating mania and hypomania in recurrent depression. Am J Psychiatry 1988; 145:804-808
66. Lewis JL, Winokur G: The induction of mania: a natural history study with controls. Arch Gen Psychiatry 1982; 39:303-306
67. Coryell W, Endicott J, Keller M: Rapid cycling affective disorder: demographics, diagnosis, family history, and course. Arch Gen Psychiatry 1992; 49:126-131
68. Angst J: The course of affective disorders. Psychopathology 1986; 19:47-52
69. Kraepelin E: Manic-Depressive Insanity and Paranoia. Translated by Barclay RM, edited by Robertson GM. Edinburgh, E & S Livingstone, 1921
70. Goodwin FK, Jamison KR: Manic-Depressive Illness. New York, Oxford University Press, 1990
71. Post RM, Rubinow DR, Ballenger JC: Conditioning and sensitization in the longitudinal course of affective illness. Br J Psychiatry 1986; 149:191-201
72. Squillace K, Post RM, Savard R, Erwin-Gorman M: Life charting of the longitudinal course of recurrent affective illness, in Neurobiology of Mood Disorders. Edited by Post RM, Ballenger JC. Baltimore, Williams & Wilkins, 1984
73. Roy-Byrne PP, Post RM, Uhde TW, Porcu T, Davis DD: The longitudinal course of recurrent affective illness: life chart data from research patients at the NIMH. Acta Psychiatr Scand Suppl 1985; 317:5-34
74. Post RM, Roy-Byrne PP, Uhde TW: Graphic representation of the life course of illness in patients with affective disorder. Am J Psychiatry 1988; 145:844-848
75. Baastrup PC, Schou M: Lithium as a prophylactic agent: its effect against recurrent depressions and manic-depressive psychosis. Arch Gen Psychiatry 1967; 16:162-172
76. Calabrese JR, Delucchi GA: Spectrum of efficacy of valproate in 55 patients with rapid-cycling bipolar disorder. Am J Psychiatry 1990; 147:431-434
77. Grof P, Angst J, Haines T: The clinical course of depression: practical issues, in Medica Hoechst 8: Classification and Prediction of Outcome of Depression. Edited by Angst J. Stuttgart, Germany, Schattauer Verlag, 1974
78. Post RM, Leverich GS, Rosoff AS, Altshuler LL: Carbamazepine prophylaxis in refractory affective disorders: a focus on long-term followup. J Clin Psychopharmacol 1990; 10:318-327
79. Spitzer RL, Endicott J, Robins E: Research Diagnostic Criteria: rationale and reliability. Arch Gen Psychiatary 1978; 35:773-782
80. Rouillon F, Lejoyeux M, Filteau MJ: Unwanted effects of long term treatment, in Long Term Treatment of Depression. Edited by Montgomery SA, Rouillon FA. New York, John Wiley & Sons, 1992
81. Maj M: Clinical prediction of response to lithium prophylaxis in bipolar patients: the importance of the previous pattern of course of illness. Clin Neuropharmacol 1990; 13(suppl 1):S66-S70
82. Faedda GL, Baldessarini RJ, Tohen M, Strakowski SM, Waternaux C: Episode sequence in bipolar disorder and response to lithium treatment. Am J Psychiatry 1991; 148:1237-1239
83. Pickar D, Cowdry RW, Zis AP, Cohen RM, Murphy DL: Mania and hypomania during antidepressant pharmacotherapy: clinical and research implications, in Neurobiology of Mood Disorders. Edited by Post RM, Ballenger J. Baltimore, Williams & Wilkins, 1984
84. Dunner DL, Patric V, Fieve RR: Rapid cycling manic depressive patients. Compr Psychiatry 1977; 18:561-566
85. Wolpert EA, Goldberg JF, Harrow M: Rapid cycling in unipolar and bipolar affective disorders. Am J Psychiatry 1990; 147:725-728
86. Dunner DL: Rapid cycling bipolar manic depressive illness. Psychiatr Clin North Am 1979; 2:461-467
87. Potter WZ, Murphy DL, Wehr TA, Linnoila M, Goodwin FK: Clorgyline: a new treatment for patients with refractory rapid cycling disorder. Arch Gen Psychiatry 1982; 39:505-510
88. Himmelhoch JM, Thase ME, Mallinger AG, Houck P: Tranylcypromine versus imipramine in anergic bipolar depression. Am J Psychiatry 1991; 148:910-916
89. McGrath PJ, Stewart JW, Harrison W, Quitkin FM: Treatment of tricyclic refractory depression with a monoamine oxidase inhibitor antidepressant. Psychopharmacol Bull 1987; 23:169-172
90. Thase ME, Mallinger AG, McKnight D, Himmelhoch JM: Treatment of imipramine-resistant depression, IV: a double-blind crossover study of tranylcypromine for anergic bipolar depression. Am J Psychiatry 1992; 149:195-198